Health
Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China
CAMBRIDGE, Mass. and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the addition of three seasoned pharmaceutical leaders,Kathy He, R...
2021-02-23 20:00
2987
New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19
SHIJIAZHUANG, China, Feb. 23, 2021 /PRNewswire/ -- Recently, Prof. Caisheng Wu and Prof.Yifeng Chai from the School of Pharmacy, Xiamen University have made new progress in the study of the pharmacologically active ingredients and mechanism of Lianhua Qingwen Capsules, developed and produced by Y...
2021-02-23 17:05
2617
Molecular Stethoscope Announces Publication of its NAFLD/NASH Study in the American Journal of Physiology - Gastrointestinal and Liver Physiology
Circulating cell-free mRNA in blood reflective of NAFLD/NASH liver pathology PALO ALTO, Calif., Feb. 23, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of its human proof-of-concept study describing the stratification of NAFLD/N...
2021-02-23 16:00
1344
Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing
* Series C financing brings total capital raised in the last 12 months to over US$ 400 million (>RMB 2.5 billion) * The proceeds will support the continued development and expansion of Clover's pipeline of protein-based vaccines and biologic cancer therapies CHENGDU, China, Feb. 23, 2021 /PRNe...
2021-02-23 10:59
2669
The BCMA CAR-T Co-developed by Innovent and IASO Was Granted Breakthrough Therapy Designation by the NMPA for the Treatment of Relapsed/Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-02-23 09:22
5710
AnchorDx Completes USD 40 Million Series C Financing to Advance Cancer Screening and Early Detection Programs
GUANGZHOU, China, Feb. 23, 2021 /PRNewswire/ -- AnchorDx Medical Co., Ltd. ("AnchorDx") announced the completion of aUSD 40 million Series C financing. This round of financing was jointly led by OrbiMed, a world-renowned biomedicine and healthcare venture capital fund, and WuXi Huiying Investment...
2021-02-23 09:02
2405
Surgical Wait Times Technology Now Available in Australia and New Zealand
Fastest Growing Canadian Health Technology Company Expands Into ANZ SYDNEY, Feb. 23, 2021 /PRNewswire/ -- Wait times in both Australia and New Zealand are too long and how patients are admitted for surgery hasn't changed in decades. Unlike elsewhere, the process is unnecessarily antiquated and ...
2021-02-23 05:00
959
SecurityHQ Release New Mobile App
LONDON, Feb. 23, 2021 /PRNewswire/ -- SecurityHQ, the leading provider in
managed security services, launch their new Mobile App, SecurityHQ Response.
2021-02-23 03:00
2676
Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A
LACHEN, Switzerland, Feb. 23, 2021 /PRNewswire/ -- Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journalThrombosis and Haemosta...
2021-02-23 00:51
2916
Frost & Sullivan Reveals Regional Trends and Cutting-edge Technologies in the Global MRI Market
Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global market SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Technological Advancements and Emerging Applications in the Global ...
2021-02-23 00:48
1252
Dr. Ren Feng Appointed as Chief Scientific Officer of Insilico Medicine
Pharmaceutical veteran joins Insilico Medicine to apply Artificial Intelligence to build a portfolio of Insilico Medicine's proprietary assets and further pipeline development HONG KONG, Feb. 22, 2021 /PRNewswire/ -- Insilico Medicine (the "Company"), a global leader in artificial intelligence f...
2021-02-22 23:28
1788
Curocell announces Korean FDA clearance of the IND for CRC01, a first in kind immune checkpoint receptors downregulated CD19 CAR-T therapy
DAEJEON, South Korea, Feb. 22, 2021 /PRNewswire/ -- Curocell, Inc., a clinical-stage biotech developing next-generation CAR-T (OVIS™) therapies, announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved its Phase 1/2 clinical study application forCRC01, CD19 CAR-T cell the...
2021-02-22 22:00
1353
Los Angeles Lakers Name Hyperice Official Recovery Technology Sponsor
First NBA Team Deal Returns the Recovery Technology Leader to its Southern California Roots EL SEGUNDO, Calif. and IRVINE, Calif., Feb. 22, 2021 /PRNewswire/ -- The Los Angeles Lakers andHyperice announced today a multi-season sponsorship agreement that names Hyperice the Official Recovery Techn...
2021-02-22 22:00
3067
BioVaxys Announces Appointment To Its Scientific Advisory Board
VANCOUVER, B.C., Feb. 22, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, today announced the appointment of Kartik Chandran Ph.D....
2021-02-22 21:00
2180
ABclonal Biotechnology Completes $93 Million Series C Financing
WOBURN, Mass., Feb. 22, 2021 /PRNewswire/ -- ABclonal Biotechnology, a global life science tools and services provider, recently completed its$92.9 million Series C financing led by Sequoia Capital China and healthcare-focused investor LYFE Capital. Other new and existing shareholders, such as Si...
2021-02-22 20:00
1672
Positive BNC210 7-Day Dosing Pharmacokinetic Study Exceeds Blood Exposure Projected for Phase 2b PTSD Trial
* BNC210 novel oral tablet formulation (900 mg given twice daily) exceeds blood exposure projected for upcoming Phase2b PTSD trial * BNC210 Phase 2b PTSD trial on target for start in mid-2021 with final dose selected ADELAIDE, Australia, Feb. 22, 2021 /PRNewswire/ -- Bionomics Limited (ASX: B...
2021-02-22 19:00
3147
Completion of Patients' Recruitment for Proxalutamide's COVID-19 Hospitalised Study
SUZHOU, China, Feb.22, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939) is pleased to announce that the clinical trial of Proxalutamide for the treatment of hospitalised COVID-19 patients inBrazil completed the recruitment of 588 patients. The data of the clinical trial is expected ...
2021-02-22 17:14
3142
Gan & Lee Announces New Partnership with International Diabetes Federation
BEIJING and BRIDGEWATER, N.J., Feb. 22, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), a global biopharmaceutical company, has announced a collaborative partnership with the International Diabetes Federation (IDF) that aims t...
2021-02-22 17:00
3498
SunRock Biopharma and GenScript ProBio Enter into a Collaboration Agreement to Develop Novel Monoclonal Antibody Program
NANJING, China, Feb. 22, 2021 /PRNewswire/ -- On February 21, 2021, GenScript ProBio and SunRock Biopharma, a company focused on the development of antibody therapeutics targeting cancer, announced a collaboration spanning preclinical discovery to large scale GMP manufacturing for SunRock's CCR9 ...
2021-02-22 16:54
1718
Sanitation and Water for All Announces New Global Leadership Council
NEW YORK, Feb. 22, 2021 /PRNewswire/ -- Today, the Sanitation and Water for All (SWA) partnership announced the formation of aGlobal Leadership Council (GLC), a high-level group of appointed SWA leaders who will advocate for universal water, sanitation and hygiene in the lead up to 2030, the dead...
2021-02-22 16:00
2000
Week's Top Stories
Most Reposted
Mastercard goes OTP-free in APAC for faster, safer online transactions
[Picked up by 326 media titles]
2024-11-06 09:00Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 309 media titles]
2024-11-12 09:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 284 media titles]
2024-11-12 11:00
Most Read
Mastercard goes OTP-free in APAC for faster, safer online transactions
2024-11-06 09:00
13117
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
10117
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
2024-11-07 11:34
7458
XTEP's First Mono Store in Malaysia Comes to Puchong
2024-11-07 10:08
6173
